Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02858622Completed
Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Total dose of rescue analgesia at 24 hours. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02858622.